Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Earlier oral trial METAOD005 randomized 300 adults with obesity to oral AOD-9604 (1, 5, 10, 20, or 30 mg/day) or placebo for 12 weeks
Dose ranges of 5 to 10 mg per injection, administered two to five times per week, represent the current clinical framework, with goal-specific and individual-specific adjustments required
Schema Markup
Even determining which form of the peptides should be used was unclear to regulators, since substances like TB-500 arent recognized as official pharmaceutical ingredients in the U.S
The isoprenaline-induced myocardial infarction model showed reduced infarct size with BPC-157 treatment
Peptide Sciences shut down in March 2026 after generating $7.4 million per month
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
